Form 4: Lifevantage Director Raymond Greer Acquires Shares

Lifevantage Corp Director Raymond B. Greer acquired 13,531 shares of common stock as part of the company's outside director compensation program.

Summary

• Raymond B. Greer, a Director of Lifevantage Corp (LFVN), acquired 13,531 shares of common stock.
• The transaction occurred on November 6, 2025.
• The shares were acquired at a price of $7.76 per share, based on the weighted average closing price for the ten trading days ending the day before the grant date.
• This acquisition is part of the issuer's outside director compensation program.
• The shares will vest in a single installment on November 6, 2026, contingent on Mr. Greer's continuous service to the issuer.
• Following this transaction, Mr. Greer beneficially owns 112,819 shares directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The filing reports a routine director stock grant, which is a neutral to slightly positive event as it aligns director interests with shareholders. No significant positive or negative financial news is contained.

Positives

• Director Raymond B. Greer received 13,531 shares, aligning his interests with shareholders.
• The grant is part of a structured outside director compensation program, indicating standard corporate governance practices.

Risks

• The vesting of the 13,531 shares is subject to Raymond B. Greer's continuous service to Lifevantage Corp through November 6, 2026.
• The value of the acquired shares is subject to market fluctuations of Lifevantage Corp's common stock.

Future Outlook

The 13,531 shares granted to Director Raymond B. Greer are scheduled to vest in a single installment on November 6, 2026, contingent upon his continuous service to the issuer until that date.

Management Comments

• "These shares were granted to the reporting person pursuant to the issuer's outside director compensation program."
• "The shares will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date."

Industry Context

This transaction represents a routine equity grant to an outside director, a common practice in publicly traded companies to align director interests with those of shareholders and to compensate for board service. It reflects standard corporate governance and compensation structures within the industry.

Comparison to Industry Standards

• The grant of equity as part of director compensation is a standard practice across most industries, including the health and wellness sector where Lifevantage operates.
• The vesting schedule, tied to continuous service, is typical for such grants, ensuring retention and long-term commitment.
• The use of a Rule 10b5-1 plan for the transaction is also a common practice for insiders to manage stock transactions in compliance with insider trading regulations.

Related Party Transactions

• The grant of 13,531 shares to Director Raymond B. Greer is a transaction between the company and a related party (an executive officer/director) as part of the established outside director compensation program.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially encouraging long-term value creation. It also represents a minor dilution if new shares are issued, or a use of treasury shares.
• Director (Raymond B. Greer): Receives equity compensation, increasing his stake and potential future wealth, contingent on continued service.

Next Steps

• The 13,531 shares granted to Raymond B. Greer are expected to vest on November 6, 2026, assuming continuous service.

Key Dates

Keywords

Lifevantage Corp, LFVN, Raymond B. Greer, Director Compensation, Stock Grant, SEC Form 4, Beneficial Ownership, Equity Acquisition, Rule 10b5-1